News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Horizon Discovery Ltd. Sign Commercial Screening Agreement with Silicos NV
August 25, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Horizon Discovery -- Horizon Discovery (Horizon) today announced it has signed a commercial agreement with Belgian computational fragment based drug discovery biotech Silicos NV (Silicos) relating to its X-MAN technology.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Europe
MORE ON THIS TOPIC
Layoff Tracker
Bayer, Leap, Atara Reduce Workforces Amid Strategic Reorganizations
May 14, 2025
·
204 min read
·
BioSpace Editorial Staff
Podcast
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
May 14, 2025
·
2 min read
·
Heather McKenzie
C-suite
Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels
May 13, 2025
·
2 min read
·
Annalee Armstrong
Earnings
Bayer’s Continued Restructuring Claims 2,000 Jobs and Thins Management Layers
May 13, 2025
·
3 min read
·
Tristan Manalac
